Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Outlook Therapeutics, Inc. - Common Stock (NQ:OTLK)

0.8042 -0.0058 (-0.72%)
Streaming Delayed Price Updated: 3:44 PM EDT, Jun 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Outlook Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
On Friday, there are stocks with unusual volume. Let's take a look. ↗
Via Chartmill
Discover the most active stocks in Thursday's session. ↗
Via Chartmill
Most active stocks in Tuesday's session ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
Gapping stocks in Tuesday's session ↗
Via Chartmill
Which stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
What's going on in today's after hours session ↗
Via Chartmill
These stocks are moving in today's session ↗
Via Chartmill
Top movers in Tuesday's session ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
Which stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
What's going on in today's after hours session ↗
Via Chartmill
Unusual volume stocks in Wednesday's session ↗
Via Chartmill
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Keep an eye on the top gainers and losers in Monday's session. ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
Discover the most active stocks in Friday's session. ↗
Via Chartmill
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
Top movers analysis in the middle of the day on 2026-01-02: top gainers and losers in today's session. ↗
Via Chartmill
Friday's session: gap up and gap down stocks ↗
Via Chartmill
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
Outlook Therapeutics Tanks Over 60% On Another FDA Blow – Here’s How Retail Is Reacting ↗
The U.S. health regulatory agency, the FDA, rejected Outlook Therapeutics’ application for approval of its drug Lytenava, which is intended to treat wet AMD. 
Via Stocktwits
Topics Workforce
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
Via Chartmill
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
Via Chartmill
News headline image
The market is filled with gapping stocks in Monday's session. ↗
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
On Monday, there are stocks with unusual volume. Let's take a look. ↗
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.